Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry

Background: Portopulmonary hypertension (PoPH) is one of the major underlying causes of pulmonary arterial hypertension (PAH). However, PoPH, especially treatment strategies, has been poorly studied. Therefore, this study evaluated current treatments for PoPH, their efficacy, and clinical outcomes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Yudai, Tamura, Yuichi, Taniguchi, Yu, Tsujino, Ichizo, Inami, Takumi, Matsubara, Hiromi, Shigeta, Ayako, Sugiyama, Yoichi, Adachi, Shiro, Abe, Kohtaro, Baba, Yuichi, Hatano, Masaru, Ikeda, Satoshi, Kusunose, Kenya, Sugimura, Koichiro, Usui, Soichiro, Takeishi, Yasuchika, Dohi, Kaoru, Hasegawa-Tamba, Saki, Horimoto, Koshin, Kikuchi, Noriko, Kumamaru, Hiraku, Tatsumi, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2022
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638513/
https://www.ncbi.nlm.nih.gov/pubmed/36408361
http://dx.doi.org/10.1253/circrep.CR-22-0098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638513/
https://www.ncbi.nlm.nih.gov/pubmed/36408361
http://dx.doi.org/10.1253/circrep.CR-22-0098

Ejemplares similares